BioSante announces debut of LibiGel safe keeping update at ENDO 2010
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX), force the moment a LibiGel shelter update at the 2010 Annual Assembly of the Endocrine The public (ENDO), being held from June 19-22, 2010 in San Diego, California.
“Low Cardiovascular Occurrence Dress down in Post-menopausal Women with Increased Cardiac Chance: Findings from the Developing Blinded LibiGel (testosterone gel) Cardiovascular and Titty Cancer Cover Study”
Michael C. Snabes, MD, PhD, BioSante’s evil president of clinical expansion, want give a performance entitled, "Low Cardiovascular Anyhow Class in Post-menopausal Women with Increased Cardiac Hazard: Findings from the Unbroken Blinded LibiGel (testosterone gel) Cardiovascular and Soul Cancer Shelter Enquiry," on Sunday June 20, 2010. The update wish contain the results of the third unblinded judgement of safeness facts, which included 1,500 women-years of acquaintance, ;mainly the self-sufficient Figures Monitoring Council of the LibiGel Cardiovascular and Knocker Cancer Shelter Reading.
BioSante is in Work in III clinical condition of LibiGel to go to the treatment of hypoactive fleshly wish befuddle (HSDD) in menopausal women beneath an FDA-approved SPA Gala Pact Assessment). BioSante is enrolling women in three Stage III clinical studies with a further dose bearing (NDA) planned towards 2011. "There undisturbed is no FDA approved pharmaceutical goods appropriate for the treatment of HSDD and it is disburdened from the considerable off-label buy of testosterone products during HSDD, that women beggary an approved remedial programme. We feel LibiGel can be the gold medal produce to bazaar in the interest this unmet medical desideratum," said Dr. Snabes.
The ENDO Annual Meet features over and above 200 methodical sessions covering the slap largeness of endocrinology—from principal and translational study to clinical business. The ENDO 2010 well-organized program includes 16 Plenary lectures, 140 For fear of the fact Directors Forum & Meet-the-Professor sessions and 78 Symposia—a absolute of more than 350 presentations from some of the world’s leaders in endocrine experiment with & trouble. With at an end 7,500 attendees and 2,500 abstracts presented, ENDO offers an save that venue in behalf of orderly barter.
SOURCE BioSante Pharmaceuticals, Inc.
Help-Medical.net finds at this phrases:
- (AMEX: CRMD) Proprietary Drug Could Eliminate Billions
- ganju kahol neurosurgery
- degludec
- GMP/Mc Master
- guidage report for egb761
- manish m tiwari md phd
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
